Lymphogranuloma venereum epidemiology and demographics

Revision as of 15:20, 18 February 2016 by Nate Michalak (talk | contribs) (→‎Age)
Jump to navigation Jump to search

Lymphogranuloma venereum Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Lymphogranuloma venereum from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphogranuloma venereum epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphogranuloma venereum epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphogranuloma venereum epidemiology and demographics

CDC on Lymphogranuloma venereum epidemiology and demographics

Lymphogranuloma venereum epidemiology and demographics in the news

Blogs on Lymphogranuloma venereum epidemiology and demographics

Directions to Hospitals Treating Lymphogranuloma venereum

Risk calculators and risk factors for Lymphogranuloma venereum epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.

Overview

While the frequency of LGV infection is thought to be rare in industrialized countries, its identification is not always obvious, so the number of cases of LGV in the United States is unknown. However, outbreaks in the Netherlands and other European countries among men who have sex with men (MSM) have raised concerns about cases of LGV in the U.S.

Epidemiology and Demographics

Incidence

Age

  • LGV is seen in sexually active individuals, ranging from ages 15 to 40 years.

Gender

  • LGV affects both sexes equally
  • Males typically present at earlier stages and females at later stages
  • LGV is commonly seen in men who have sex with men (MSM) presenting as proctitis[1]

Race

Developed Countries

Developing Countries

References

  1. Ward H, Alexander S, Carder C, Dean G, French P, Ivens D; et al. (2009). "The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study". Sex Transm Infect. 85 (3): 173–5. doi:10.1136/sti.2008.035311. PMC 2683989. PMID 19221105.

Template:WikiDoc Sources